Detalhe da pesquisa
1.
Switching to Tirzepatide 5 mg From Glucagon-Like Peptide-1 Receptor Agonists: Clinical Expectations in the First 12 Weeks of Treatment.
Endocr Pract
; 2024 May 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38723893
2.
Efficacy and Safety of Mirikizumab in a Randomized Phase 2 Study of Patients With Crohn's Disease.
Gastroenterology
; 162(2): 495-508, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34748774
3.
Achievement of glycaemic targets with weight loss and without hypoglycaemia in type 2 diabetes with the once-weekly glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonist tirzepatide: A post hoc analysis of the SURPASS-1 to -5 studies.
Diabetes Obes Metab
; 25(4): 965-974, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36514843
4.
Lasmiditan efficacy in the acute treatment of migraine was independent of prior response to triptans: Findings from the CENTURION study.
Cephalalgia
; 42(1): 20-30, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34644189